Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural... see more

Recent & Breaking News (CSE:PHRX)

Aura Provides Update on Pharmadrug and Its European Strategy

GlobeNewswire June 5, 2019

Aura Announces Appointment of Al Quong to Its Board of Directors

GlobeNewswire May 31, 2019

Aura Initiates Investor Relations Strategy

GlobeNewswire May 24, 2019

Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug

GlobeNewswire May 17, 2019

Aura Announces Supply Agreement With FSD Pharma & Conditions Met to Close German Acquisition

GlobeNewswire May 8, 2019

Aura Signs Definitive Agreement Disposing of U.S. Cannabis Certification Clinics

GlobeNewswire May 1, 2019

Aura Closes 2nd Tranche of $5.8 Million Subscription Receipt

Stockhouse Editorial April 18, 2019

Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Transaction

GlobeNewswire April 17, 2019

Aura Announces Appointment of Alain Dobkin to its Board of Directors

GlobeNewswire March 26, 2019

Aura Announces Signing of Definitive Share Purchase Agreement to Acquire Licenced Medical Cannabis Distributor in Germany

GlobeNewswire February 28, 2019

Aura Health Announces Closing of $1.9 Million on the First Tranche of Subscription Receipt Financing

GlobeNewswire February 27, 2019

Aura Health Provides Further Clarity Regarding Offering and Strategic Investor

GlobeNewswire February 22, 2019

With a Strategic Investment by Aleafia Health, Aura Health Announces Increase to Previously Announced Brokered Subscription Receipt Financing to $7.26 Million

GlobeNewswire February 21, 2019

Aura Health Announces Pricing of Previously Announced $5.0 Million Brokered Subscription Receipt Financing

GlobeNewswire February 8, 2019

Aura Health Announces $5 Million Brokered Subscription Receipt Financing

GlobeNewswire February 4, 2019

Diversified Cannabis Company Establishes Strong EU Footprint

Jeff Nielson February 1, 2019

Israel Passes Cannabis Export Law, Paving Path for Aura’s European Distribution

GlobeNewswire January 28, 2019

IIROC Trade Resumption - BUZZ

Canada NewsWire January 25, 2019

Aura Announces Binding LOI to Acquire Licenced Medical Cannabis Distributor in Germany

GlobeNewswire January 25, 2019

IIROC Trading Halt - BUZZ

Canada NewsWire January 24, 2019